IL113917A0 - Cefixime composition - Google Patents

Cefixime composition

Info

Publication number
IL113917A0
IL113917A0 IL11391795A IL11391795A IL113917A0 IL 113917 A0 IL113917 A0 IL 113917A0 IL 11391795 A IL11391795 A IL 11391795A IL 11391795 A IL11391795 A IL 11391795A IL 113917 A0 IL113917 A0 IL 113917A0
Authority
IL
Israel
Prior art keywords
cefixime
micron
max
particles
suspensions
Prior art date
Application number
IL11391795A
Other languages
English (en)
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of IL113917A0 publication Critical patent/IL113917A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
IL11391795A 1994-05-31 1995-05-30 Cefixime composition IL113917A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4418957A DE4418957A1 (de) 1994-05-31 1994-05-31 Cefixim-Zubereitung

Publications (1)

Publication Number Publication Date
IL113917A0 true IL113917A0 (en) 1995-08-31

Family

ID=6519407

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11391795A IL113917A0 (en) 1994-05-31 1995-05-30 Cefixime composition

Country Status (25)

Country Link
US (1) US5776926A (no)
EP (1) EP0685232B1 (no)
JP (1) JPH07330607A (no)
KR (1) KR950031077A (no)
CN (1) CN1117383A (no)
AT (1) ATE190844T1 (no)
AU (1) AU694201B2 (no)
CA (1) CA2150442A1 (no)
CO (1) CO4410174A1 (no)
CZ (1) CZ138595A3 (no)
DE (2) DE4418957A1 (no)
DK (1) DK0685232T3 (no)
ES (1) ES2146265T3 (no)
FI (1) FI952629A (no)
GR (1) GR3033704T3 (no)
HU (1) HU218217B (no)
IL (1) IL113917A0 (no)
NO (1) NO952138L (no)
NZ (1) NZ272216A (no)
PE (1) PE18796A1 (no)
PL (1) PL308838A1 (no)
PT (1) PT685232E (no)
SK (1) SK72795A3 (no)
TW (1) TW301610B (no)
ZA (1) ZA954427B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2231369T3 (es) * 1996-02-29 2005-05-16 Fujisawa Pharmaceutical Co., Ltd. Granulo de disgregacion rapida de un edulcorante sintetico que contiene acido silicico y/o dioxido de silicio.
TW200404550A (en) * 2002-07-08 2004-04-01 Sankyo Co Cepharospolin formulation for oral use
MXPA06012944A (es) * 2004-05-10 2007-02-12 Lupin Ltd Nueva formulaci??n farmaceutica de cefixima con mejor biodisponibilidad.
US9241905B2 (en) 2006-04-13 2016-01-26 Lupin Limited Pharmaceutical compositions of Cefixime
US9233112B2 (en) 2006-04-13 2016-01-12 Lupin Limited Pharmaceutical compositions of cefixime
CN103301068B (zh) * 2013-07-08 2014-09-10 广东彼迪药业有限公司 一种头孢克肟干混悬剂剂及其制备方法
CA2914468A1 (en) * 2013-07-18 2015-01-22 Sandoz Ag Powder mixtures for antibiotic dry syrup formulations
US11173163B2 (en) * 2015-08-05 2021-11-16 Cmpd Licensing, Llc Topical antimicrobial compositions and methods of formulating the same
US11684567B2 (en) 2015-08-05 2023-06-27 Cmpd Licensing, Llc Compositions and methods for treating an infection
US11793783B2 (en) 2015-08-05 2023-10-24 Cmpd Licensing, Llc Compositions and methods for treating an infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996355A (en) * 1975-01-02 1976-12-07 American Home Products Corporation Permanent suspension pharmaceutical dosage form
DE3804841A1 (de) * 1988-02-17 1989-08-31 Hoechst Ag Cephalosporinderivate und verfahren zu ihrer herstellung
US5409917A (en) * 1991-03-05 1995-04-25 Marvin S. Towsend Topical treatment of acne with cephalosporins

Also Published As

Publication number Publication date
PL308838A1 (en) 1995-12-11
CA2150442A1 (en) 1995-12-01
CO4410174A1 (es) 1997-01-09
ATE190844T1 (de) 2000-04-15
FI952629A (fi) 1995-12-01
SK72795A3 (en) 1996-01-10
DE59508024D1 (de) 2000-04-27
AU694201B2 (en) 1998-07-16
DE4418957A1 (de) 1995-12-07
DK0685232T3 (da) 2000-08-21
CZ138595A3 (en) 1996-04-17
GR3033704T3 (en) 2000-10-31
HU9501570D0 (en) 1995-07-28
FI952629A0 (fi) 1995-05-30
NO952138D0 (no) 1995-05-30
TW301610B (no) 1997-04-01
NO952138L (no) 1995-12-01
US5776926A (en) 1998-07-07
PT685232E (pt) 2000-08-31
HUT74421A (en) 1996-12-30
AU2033595A (en) 1995-12-07
CN1117383A (zh) 1996-02-28
ZA954427B (en) 1996-01-24
EP0685232A3 (de) 1996-05-08
ES2146265T3 (es) 2000-08-01
HU218217B (hu) 2000-06-28
PE18796A1 (es) 1996-06-04
EP0685232A2 (de) 1995-12-06
EP0685232B1 (de) 2000-03-22
JPH07330607A (ja) 1995-12-19
KR950031077A (ko) 1995-12-18
NZ272216A (en) 1996-05-28

Similar Documents

Publication Publication Date Title
CA2151967A1 (en) Magnetic nanocomposite compositions and processes for the preparation and use thereof
IL131796A0 (en) Zinc free insulin crystals for use in pulmonary compositions
WO1999017716A3 (en) Dental materials having a nanoscale filler
CA2142126A1 (en) Inhalation powder containing antistatic agent
AU5135493A (en) Composites and polymer compositions for making the same
EP0835908A4 (en) RESIN COMPOSITION AND RESIN COMPOSITION FOR SECONDARY BATTERY
AU3844893A (en) Novel dispersable polydextrose, compositions containing same and methods for the preparation thereof
CA2003391A1 (en) Silicone hairspray compositions
CA2179645A1 (en) Ultrafine reactive silica particles, suspension containing the same, and hard coating composition
TW349849B (en) Xanthan gelling agents
HU9501570D0 (en) Cephixime composition
HUT47369A (en) Acaricide and fungicide compositions containing substituted 1,4-naphtoquinones and process for producing the active components
MY111149A (en) Improved fatty compositions with high solids content.
TW334467B (en) Latex compositions and films
IE900709L (en) Pharmaceutical composition which contains a pharmaceutically¹suitable carrier and the compound having the structure¹(7ó,17ó)-17-hydroxy-7-methyl-19-nor-17-pregn-5(10)-en-20-yn-¹3-one
IL99501A0 (en) Interleukin 9 receptors,methods for the use thereof and pharmaceutical compositions containing the same
HUT41230A (en) Pesticide compositions containing substituted 4,5-dihydro-1,3,4-thiadiazol derivatives as active agents and process for producing the active agents
EP0700988A3 (de) Anwendung und Zusammensetzungen mit Difluormethoxy-2,2,2-trifluorethan
USD287867S (en) Bar exerciser
AU3454984A (en) 1,z-dithiolanes and pharmaceutical compositions
AU7027091A (en) Surface-treated fillers and rubber compositions containing the same
HU9402648D0 (en) 3,4-dioxo-1-cyclobuten-1-yl-substituted (indolyl-alkyl)-pyridine- and -pyrimidine derivatives and antimigraine composition containing them as active componens
HUT46838A (en) Pesticide compositions containing 2,5-bis-pyridyl-1,3,4-thiadiazol derivatives as active components and process for producing the active components
AU3322589A (en) Lubricant
USD282496S (en) Resuscitator for newborn pigs